JP2004518425A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004518425A5 JP2004518425A5 JP2002552961A JP2002552961A JP2004518425A5 JP 2004518425 A5 JP2004518425 A5 JP 2004518425A5 JP 2002552961 A JP2002552961 A JP 2002552961A JP 2002552961 A JP2002552961 A JP 2002552961A JP 2004518425 A5 JP2004518425 A5 JP 2004518425A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- polynucleotide
- complex
- stem cell
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229920001184 polypeptide Polymers 0.000 description 46
- 102000004196 processed proteins & peptides Human genes 0.000 description 46
- 108090000765 processed proteins & peptides Proteins 0.000 description 46
- 108091033319 polynucleotide Proteins 0.000 description 38
- 102000040430 polynucleotide Human genes 0.000 description 38
- 239000002157 polynucleotide Substances 0.000 description 38
- 238000000034 method Methods 0.000 description 19
- 210000000130 stem cell Anatomy 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 8
- 230000010261 cell growth Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 125000003275 alpha amino acid group Chemical group 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 108700008625 Reporter Genes Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 102100032528 C-type lectin domain family 11 member A Human genes 0.000 description 1
- 101710167766 C-type lectin domain family 11 member A Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2000/035260 WO2001053500A1 (en) | 1999-12-23 | 2000-12-23 | Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides |
| PCT/IB2001/002839 WO2002051868A2 (en) | 2000-12-23 | 2001-07-25 | Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004518425A JP2004518425A (ja) | 2004-06-24 |
| JP2004518425A5 true JP2004518425A5 (https=) | 2008-07-24 |
Family
ID=21742103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002552961A Withdrawn JP2004518425A (ja) | 2000-12-23 | 2001-07-25 | 幹細胞成長因子様ポリペプチドおよびポリヌクレオチドに関連した方法および物質 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20060074044A1 (https=) |
| EP (1) | EP1345965A2 (https=) |
| JP (1) | JP2004518425A (https=) |
| AU (1) | AU2002241189A1 (https=) |
| WO (1) | WO2002051868A2 (https=) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4491632A (en) * | 1979-10-22 | 1985-01-01 | The Massachusetts General Hospital | Process for producing antibodies to hepatitis virus and cell lines therefor |
| US4444887A (en) * | 1979-12-10 | 1984-04-24 | Sloan-Kettering Institute | Process for making human antibody producing B-lymphocytes |
| US4341761A (en) * | 1980-07-25 | 1982-07-27 | E. I. Du Pont De Nemours And Company | Antibodies to immunogenic peptides and their use to purify human fibroblast interferon |
| US4472506A (en) * | 1981-01-13 | 1984-09-18 | Liburdy Robert P | Method for determining cell membrane dielectric breakdown |
| US4466917A (en) * | 1981-02-12 | 1984-08-21 | New York University | Malaria vaccine |
| US4493890A (en) * | 1981-03-23 | 1985-01-15 | Miles Laboratories, Inc. | Activated apoglucose oxidase and its use in specific binding assays |
| US4451570A (en) * | 1981-03-26 | 1984-05-29 | The Regents Of The University Of California | Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line |
| US4399121A (en) * | 1981-11-04 | 1983-08-16 | Miles Laboratories, Inc. | Iodothyronine immunogens and antibodies |
| US4427783A (en) * | 1981-12-14 | 1984-01-24 | Hoffmann-La Roche Inc. | Immunoassay of thymosin α1 |
| EP1208195A2 (en) * | 1999-06-15 | 2002-05-29 | Genentech Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US6569662B1 (en) * | 2000-01-21 | 2003-05-27 | Hyseq, Inc. | Nucleic acids and polypeptides |
| CA2395443A1 (en) * | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides |
| JP2004527210A (ja) * | 2000-08-02 | 2004-09-09 | ザ ジョンズ ホプキンス ユニバーシティー | 内皮細胞発現パターンの評価法 |
-
2001
- 2001-07-25 WO PCT/IB2001/002839 patent/WO2002051868A2/en not_active Ceased
- 2001-07-25 EP EP01988101A patent/EP1345965A2/en not_active Withdrawn
- 2001-07-25 AU AU2002241189A patent/AU2002241189A1/en not_active Abandoned
- 2001-07-25 JP JP2002552961A patent/JP2004518425A/ja not_active Withdrawn
-
2005
- 2005-11-18 US US11/283,290 patent/US20060074044A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gronewold et al. | The act operon controls the level and time of C‐signal production for Myxococcus xanthus development | |
| JP2005046146A5 (https=) | ||
| EP1403366B1 (en) | Genes with es cell-specific expression | |
| JP2002502589A5 (https=) | ||
| JP2002521055A5 (https=) | ||
| JP2002518010A5 (https=) | ||
| CA2479476A1 (en) | Compositions and methods for the treatment of tumor | |
| JP2004267216A5 (https=) | ||
| JP2005027667A5 (https=) | ||
| JP2004138610A5 (https=) | ||
| JP2008545436A5 (https=) | ||
| ATE393828T1 (de) | Nukleotidsequenzen, die für sekretierte polypeptide aus mycobacterium kodieren, vektoren, die diese enthalten, und anwendungen zur diagnostik und verhütung von tuberkulose | |
| JP2004513614A5 (https=) | ||
| JP2005518212A5 (https=) | ||
| CA2221409A1 (en) | Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same | |
| JP2005511023A5 (https=) | ||
| JP2003530821A5 (https=) | ||
| CN111676273B (zh) | 一种检测牛成肌细胞hmga2基因增强子的方法 | |
| JP2002523094A5 (https=) | ||
| JP2007508020A5 (https=) | ||
| JP2004515215A5 (https=) | ||
| JP2004518425A5 (https=) | ||
| JP2002542825A5 (https=) | ||
| JP2004290197A5 (https=) | ||
| US7160994B2 (en) | Osteoclast-specific genes and proteins and uses thereof |